Skip to main content

Table 2 Effect of zosuquidar on mitoxantrone accumulation in K562/BCRP and K562/Vec cells

From: Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)

  FTC (10 μM) Zosuquida
K562/Vec 0 0
K562/BCRP 0.59 ± 0.11 0.04 ± 0.07